Antibiotic Toxicity

Clinical trial pipeline · Data from ClinicalTrials.gov

See which Antibiotic Toxicity trials you may qualify for

Total trials

Actively recruiting

Phase 3 trials

Completed

Trial phase breakdown

Trial status

Actively recruiting — 1 trial

RecruitingPhase 1

NCT06860802

Precision Antibiotic Dosing for Appendectomy

This research is studying a drug called cefoxitin already approved by the Food and Drug Administration (FDA) to reduce the risk of infection after surgery to re…

United States46 participantsStarted 2025-02-28

Treatment: Cefoxitin

All recent trials (17 shown)

CompletedNot Applicable

NCT05960006

A Study to Determine Pharmacokinetic Changes of Ceftriaxone in Patients With Liver Cirrhosis

The investigators designed an observational multicenter explorative in vivo study to investigate the changes in ceftriaxone pharmacokinetics in blood and ascite…

Netherlands20 participantsStarted 2023-07-10

Treatment: No intervention (observational study)

CompletedNot Applicable

NCT03790631

The OPTIMAL TDM Study: Determining Optimal Beta-lactam Plasma Concentrations Through Therapeutic Drug Monitoring

Little is known of beta-lactam antibiotics' true therapeutic plasma concentration range. The aims of this study are to define evidence-based, safe and effective…

Switzerland771 participantsStarted 2019-01-14

Treatment: The study is observational.

Antibiotic Toxicity

Trial phase breakdown

Trial status

Actively recruiting — 1 trial

Precision Antibiotic Dosing for Appendectomy

All recent trials (17 shown)

A Study to Determine Pharmacokinetic Changes of Ceftriaxone in Patients With Liver Cirrhosis

The OPTIMAL TDM Study: Determining Optimal Beta-lactam Plasma Concentrations Through Therapeutic Drug Monitoring

Trial phase breakdown

Trial status

Actively recruiting — 1 trial

Precision Antibiotic Dosing for Appendectomy

All recent trials (17 shown)

A Study to Determine Pharmacokinetic Changes of Ceftriaxone in Patients With Liver Cirrhosis

The OPTIMAL TDM Study: Determining Optimal Beta-lactam Plasma Concentrations Through Therapeutic Drug Monitoring

Efficacy and Safety of Antimicrobial Durations Treatment of Infections Associated With Osteosynthesis Material

Risk Factors and Machine Learning Model for Beta-Lactam Drugs Related Acute Kidney Injury

A Pharmacokinetic Study of Polymyxin B in Healthy Subjects and Subjects With Renal Insufficiency

Peritoneal Diffusion and Efficacy of Antibiotic Therapy in Pediatric Peritonitis

Antidote for Valproic Acid Toxicity: a New Indication for Meropenem Antibiotic.

Target Attainment of TDM-guided Infusion of Piperacillin/Tazobactam and Cefepim in Critically Ill Patients

First Line Antimicrobials in Children With Complicated Severe Acute Malnutrition

Pegylated Liposomal Doxorubicin Versus Pirarubicin Plus Ifosfamide, Dacarbazine in Locally Advanced, Unresectable or Met…

Antibiotic Prophylaxis in Transurethral Prostate Resection (TURP) and Transurethral Bladder Tumour Resection (TURB)

AvenovaTM as a Sterile Skin Preparation Agent

Computer-based Dosage Calculation for Antibiotics

Lactobacillus Reuteri in the Prevention of Antibiotic Associated-diarrhea and Clostridium Difficile

Nanosilver Fluoride to Prevent Dental Biofilms Growth

Towards Reducing Resistance and Hematological Toxicity of Linezolid